Literature DB >> 8185170

Cholecystokinin stimulates Ca2+ mobilization and clonal growth in small cell lung cancer through CCKA and CCKB/gastrin receptors.

T Herget1, T Sethi, S V Wu, J H Walsh, E Rozengurt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8185170     DOI： 10.1111/j.1749-6632.1994.tb44076.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  4 in total

1.  Electrophysiological studies of the cholecystokininA receptor antagonists SR27897B and PD140548 in the rat isolated nodose ganglion.

Authors:  P M Beart; E Krstew; R E Widdop
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-05       Impact factor: 3.000

2.  Inter- and intraspecies polymorphisms in the cholecystokinin-B/gastrin receptor alter drug efficacy.

Authors:  A S Kopin; E W McBride; M C Gordon; S M Quinn; M Beinborn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

Review 3.  Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy.

Authors:  Mahjabin Khan; Tao Huang; Cheng-Yuan Lin; Jiang Wu; Bao-Min Fan; Zhao-Xiang Bian
Journal:  Oncotarget       Date:  2017-06-07

4.  Regulation of mammalian gastrin/CCK receptor (CCK2R) expression in vitro and in vivo.

Authors:  H Louise Ashurst; Andrea Varro; Rod Dimaline
Journal:  Exp Physiol       Date:  2007-10-12       Impact factor: 2.969
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.